HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abraha Habtemariam Selected Research

formic acid (formate)

7/2021Osmium(ii) tethered half-sandwich complexes: pH-dependent aqueous speciation and transfer hydrogenation in cells.
5/2018Effect of sulfonamidoethylenediamine substituents in RuII arene anticancer catalysts on transfer hydrogenation of coenzyme NAD+ by formate.
5/2018Reversible pH-Responsive Behavior of Ruthenium(II) Arene Complexes with Tethered Carboxylate.
1/2018Asymmetric transfer hydrogenation by synthetic catalysts in cancer cells.
12/2015Half-sandwich rhodium(III) transfer hydrogenation catalysts: Reduction of NAD(+) and pyruvate, and antiproliferative activity.
3/2015Transfer hydrogenation catalysis in cells as a new approach to anticancer drug design.
6/2006Catalysis of regioselective reduction of NAD+ by ruthenium(II) arene complexes under biologically relevant conditions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Abraha Habtemariam Research Topics

Disease

25Neoplasms (Cancer)
12/2021 - 12/2005
22Ovarian Neoplasms (Ovarian Cancer)
03/2022 - 12/2005
4Lung Neoplasms (Lung Cancer)
03/2022 - 06/2006
3Prostatic Neoplasms (Prostate Cancer)
03/2018 - 12/2017
2Breast Neoplasms (Breast Cancer)
07/2021 - 01/2017
1Phototoxic Dermatitis (Phototoxicity)
01/2017
1Colonic Neoplasms (Colon Cancer)
06/2015
1Carcinoma (Carcinomatosis)
06/2011

Drug/Important Bio-Agent (IBA)

15Cisplatin (Platino)FDA LinkGeneric
03/2022 - 06/2011
10Pharmaceutical PreparationsIBA
03/2022 - 05/2007
8LigandsIBA
11/2018 - 12/2005
7formic acid (formate)IBA
07/2021 - 06/2006
4Reactive Oxygen Species (Oxygen Radicals)IBA
03/2022 - 04/2014
4pyridineIBA
05/2018 - 12/2006
4RutheniumIBA
03/2018 - 12/2006
4DNA (Deoxyribonucleic Acid)IBA
01/2016 - 09/2008
3NAD (NADH)IBA
05/2018 - 04/2012
3OsmiumIBA
01/2016 - 11/2010
3IridiumIBA
03/2015 - 06/2011
3ethylenediamine (ethylenediamine dihydroiodide)FDA Link
06/2011 - 02/2006
2MetalsIBA
11/2018 - 03/2015
2Proteins (Proteins, Gene)FDA Link
11/2017 - 06/2011
2Photosensitizing Agents (Photosensitizers)IBA
11/2017 - 08/2016
2IminesIBA
01/2016 - 10/2009
2diphenyl (biphenyl)IBA
11/2010 - 02/2006
2hydroxide ionIBA
12/2008 - 12/2006
1Buthionine SulfoximineIBA
03/2022
1CurcuminIBA
12/2021
1picolinic acid (chromium picolinate)IBA
07/2021
1Lactic Acid (Lactate)FDA LinkGeneric
07/2021
1OxidesIBA
11/2018
1Hydroxyl RadicalIBA
11/2018
1AnionsIBA
05/2018
1N-Formylmethionine (Formylmethionine, N)IBA
01/2018
1PolymersIBA
01/2018
1EnzymesIBA
01/2018
1AntioxidantsIBA
12/2017
1Aldehyde Reductase (Aldose Reductase)IBA
11/2017
1Histidine (L-Histidine)FDA Link
11/2017
1HydrogelsIBA
01/2017
1Radioisotopes (Radionuclides)IBA
01/2017
1CymenesIBA
01/2017
1Glutathione (Reduced Glutathione)IBA
01/2017
1Chlorpromazine (Thorazine)FDA Link
08/2016
1TEMPOIBA
08/2016
19-ethylguanineIBA
06/2015
19-methyladenineIBA
06/2015
1PlatinumIBA
10/2014
1Vinblastine (Vinblastine Sulfate)FDA Link
11/2013
1PhenanthrolinesIBA
04/2012
1Peptides (Polypeptides)IBA
09/2011
12,2'-Dipyridyl (2,2 Bipyridine)IBA
06/2011
12-phenylpyridineIBA
06/2011
14-cymene (p-cymene)IBA
11/2010
1AminesIBA
10/2009
1Carboplatin (JM8)FDA LinkGeneric
05/2007
1pyrazoleIBA
12/2006
1hexamethylbenzeneIBA
12/2005
1AzidesIBA
12/2005

Therapy/Procedure

2Therapeutics
01/2018 - 12/2017